PK

Prafulla Kanubhai Thakkar

Active Director Director DIN 06545511
DIN 06545511 First appointment Mar 2001 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2001
Shareholding value β€’β€’β€’β€’ Premium profile

About Prafulla Kanubhai Thakkar

Data last updated:

Prafulla Kanubhai Thakkar is a Director at Cyto Pharmaceuticals Private Limited (since 2001). The company operates in Pharma.

DIN 06545511
Primary Designation Director
Industry Pharma
First Appointment 01 Mar 2001
Oldest Company Age 41 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cyto Pharmaceuticals Private Limited U24110MH1985PTC035226
Director01 Mar 20011985Active

Board colleagues of Prafulla Kanubhai Thakkar

NameDINCompanyDesignation
Nitin Bhikhubhai Kanadia05128160Cyto Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cyto Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prafulla Kanubhai Thakkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prafulla Kanubhai Thakkar

Prafulla Kanubhai Thakkar currently holds 1 directorship: Cyto Pharmaceuticals Private Limited (Director, since 01 Mar 2001).

Prafulla Kanubhai Thakkar was first appointed on 01 Mar 2001 as Director at Cyto Pharmaceuticals Private Limited.

The current boards of Prafulla Kanubhai Thakkar's companies include Nitin Bhikhubhai Kanadia (Cyto Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available